Exagen Inc

Healthcare · Diagnostics & Research

8.20$ -3.2% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

Exagen Inc (XGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 52 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet XGN
Line item	Q3 14	Q4 14	Q1 15	Q2 15	Q3 15	Q4 15	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	17	17	16	16	16	15	–	–	29	29	31	33	93	88	85	81	80	78	138	133	128	123	122	108	102	86	79	64	61	57	51	49	44	45	40	59	63	58	52	52
Current Assets	7.6	5.1	4.0	3.7	3.6	3.9	–	–	21	21	23	25	86	81	78	73	73	71	129	125	118	113	104	89	82	73	66	51	49	48	42	41	36	36	33	51	53	49	44	43
Cash	7.1	4.6	3.5	2.9	2.7	2.5	–	–	13	13	14	16	78	72	69	64	61	57	118	113	107	99	90	76	69	62	52	31	28	36	27	24	22	22	11	30	36	32	22	25
Cash & Short-Term Investments	7.1	4.6	3.5	2.9	2.7	2.5	–	–	0.0	13	14	16	78	72	69	64	61	57	118	113	107	99	90	76	69	62	52	31	28	36	27	24	22	22	11	30	36	32	22	25
Receivables	–	–	–	–	–	–	–	–	6.0	6.0	6.4	6.7	6.2	5.7	5.8	7.3	9.3	8.9	8.2	8.8	9.2	9.7	11	9.6	11	6.1	9.3	16	17	6.6	11	12	9.4	7.8	15	15	11	11	16	12
Inventory	–	–	–	–	–	–	–	–	0.0	1.0	0.0	0.9	0.9	1.4	–	1.6	1.0	1.2	2.2	2.2	1.4	1.1	1.0	2.0	1.4	1.8	1.7	1.7	2.2	2.9	2.1	2.9	2.9	–	–	–	3.5	–	–	–
Property, Plant & Equipment	–	–	–	–	–	–	–	–	1.6	1.6	1.2	1.2	1.3	1.4	1.4	1.4	1.8	2.1	2.4	3.1	3.4	4.8	12	13	13	13	13	–	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	5.5	5.5	5.5	5.5	5.5	5.5	–	–	5.5	5.5	5.5	5.5	5.5	5.5	5.5	5.5	5.5	5.5	5.5	5.5	5.5	5.5	5.5	5.5	5.5	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	0.9	0.8	0.8	0.7	0.6	0.5	–	–	0.0	0.0	0.0	0.0	–	–	–	–	–	–	5.5	5.5	–	–	–	5.5	5.5	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	29	31	33	31	34	37	–	–	34	36	31	34	34	33	34	33	36	37	36	37	37	39	46	44	45	44	43	32	33	34	31	32	31	35	34	38	45	41	38	40
Current Liabilities	22	26	28	29	32	35	–	–	9.0	9.0	5.6	6.7	7.7	5.9	7.3	5.8	8.3	8.8	7.9	8.3	8.1	9.3	12	9.6	11	9.6	9.3	8.6	10	12	8.8	9.4	8.8	14	14	10	13	14	13	13
Short-Term Debt	18	19	20	19	21	26	–	–	0.0	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.3	0.3	0.4	0.5	0.6	0.6	1.5	1.7	1.7	1.9	2.0	2.0	1.9	1.2	1.7	1.8	1.8	1.7	3.7	1.8	3.0	3.0	3.0	1.6
Accounts Payable	2.4	1.8	2.2	1.4	1.0	2.2	–	–	1.3	1.3	1.1	1.5	1.2	1.5	2.6	1.4	2.5	3.0	2.2	2.5	1.5	2.5	4.2	3.1	3.7	3.0	1.9	1.3	1.7	3.1	1.5	2.3	1.1	4.1	4.5	2.5	3.6	4.2	4.2	4.4
Long-Term Debt	–	–	–	–	–	–	–	–	25	25	25	25	26	26	26	26	26	27	27	27	27	27	28	28	28	29	29	19	19	19	19	20	20	20	18	22	22	22	22	22
Shareholders' Equity	-12	-14	-17	-16	-19	-22	–	–	-112	-6.7	-0.4	-0.7	59	56	51	48	44	42	101	96	91	85	76	64	56	42	36	32	28	23	20	18	13	9.5	6.4	21	18	17	14	12
Retained Earnings	-87	-89	-93	-102	-106	-108	–	–	-153	-153	-156	-158	-161	-165	-170	-174	-178	-181	-187	-194	-201	-208	-218	-232	-241	-256	-263	-268	-274	-279	-283	-286	-291	-294	-298	-303	-310	-314	-318	-321
Shares Outstanding	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.5	13	13	13	13	13	13	17	17	17	17	17	17	17	18	18	18	18	18	18	18	18	19	21	23	22	24	24

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings